Forecast

The analysts' average price target is +12,43€ (+1.328,74%). The median is +9,46€ (+987,36%).

Buy	9
Hold	11
Sell	7

News Go to news feed

Canopy Growth: analysts see smaller loss and revenue increase in latest quarter

Canopy Growth expects to release quarterly results for the period ended March 31, 2026, likely on June 15, 2026. Four analysts on average forecast an earnings decline to -0.102 CAD per share versus -1.430 CAD a year ago. Six analysts estimate quarterly revenue at 74.3 million CAD, up 14.27% from 65.0 million CAD in the year-ago quarter. For the fiscal year, seven analysts project total revenue of 286.0 million CAD and an average annual loss of -0.459 CAD per share versus -5.560 CAD in the prior year. » More on finanzen.net
Canopy Growth misses EPS guidance in Q3 2026, beats revenue forecasts

Canopy Growth reported Q3 2026 EPS of -0.18 CAD (expectation: -0.04 CAD), significantly missing the estimate, while revenue of 74.54 million CAD exceeded the expected 50.88 million CAD by 46.5%. Adjusted EBITDA loss was reduced to 3 million CAD, the strongest result to date. Management aims for positive adjusted EBITDA by fiscal 2027, relying on operational efficiency, cost discipline and the acquisition of MTL Cannabis to improve margins. The stock moved only slightly premarket, trading around 1.08 CAD. » More on de.investing.com

Financials

In the last quarter, CANOPY GROWTH had revenue of 50.06m€ and net profit of −8.99m€

(EUR)	Jun 2026	YoY
Revenue	+50.06m	11,28%
Gross profit	+13.71m	21,93%
Net profit	−8.99m	65,28%
EBITDA	−2.88m	78,82%

Fundamentals

Metric	Value
Market capitalization	+387.87m€
Number of shares	422.15m
52-week high/low	+2,04€ - +0,72€
Dividends	No
Beta	2,41
P/E ratio	−2,20
PEG ratio	−0,01
P/B ratio	+0,90
P/S ratio	+0,83

Company profile

Die Canopy Growth Corporation ist zusammen mit ihren Tochtergesellschaften in der Produktion, dem Vertrieb und dem Verkauf von Cannabis- und Hanfprodukten für Freizeit- und medizinische Zwecke hauptsächlich in Kanada, den Vereinigten Staaten und Deutschland tätig. Das Unternehmen ist in zwei Segmenten tätig: Global Cannabis und andere Verbraucherprodukte. Zu den Produkten des Unternehmens gehören getrocknete Cannabisblüten, Extrakte und Konzentrate, Getränke, Gummibärchen und Vapes. Es bietet seine Produkte unter den Marken Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, und Truverra an. Das Unternehmen war früher als Tweed Marijuana Inc. bekannt und änderte im September 2015 seinen Namen in Canopy Growth Corporation. Canopy Growth Corporation wurde 2009 gegründet und hat seinen Hauptsitz in Smiths Falls, Kanada.

Name	CANOPY GROWTH
CEO	Luc Mongeau
Headquarters	Smiths Falls, on Canada
Website	canopygrowth.com
Sector	Health Care
Industry	Pharmaceuticals
IPO	04/07/2014
Employees	1.128